NCT00313391View on ClinicalTrials.gov

Risperdal Consta and Health Care Utilization in Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Risperdal Consta

Trial Locations (1)

Unknown

Grady Hospital, Atlanta

All Listed Sponsors
collaborator

Janssen, L.P. - Investigator Initiated Studies Program

UNKNOWN

lead

Emory University

OTHER

NCT00313391 - Risperdal Consta and Health Care Utilization in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter